During early tumor lesions, TAMs are recruited in a HCC environment mainly via CSF-1, CCL2, VEGF, and TGF-β, and in turn release additional cytokines, chemokines, and growth factors that promote HCC progression (59). The gene discussed is CCL2; the disease is neoplasm.